Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

ICAM2 is related to good prognosis in dendritic cell immunotherapy for cancer.

  • Authors : da Silva SF; Oncology Research Institute (IPON), Federal University of Triângulo Mineiro (UFTM), Uberaba, MG, Brazil.; Murta EF

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Dendritic Cells* ; Immunotherapy*

  • Source: Immunotherapy [Immunotherapy] 2024 Feb; Vol. 16 (3), pp. 173-185. Date of Electronic Publication: 2023 Dec 21.Publisher: Future Medicine Country of Publication: England NLM ID: 101485158 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy.

  • Authors : Song J; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Nanchang University, No.1 MinDe Road, Nanchang 330006, Jiangxi, China; School of Ophthalmology and Optometry, Nanchang University, Nanchang 330006, Jiangxi, China.

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/therapy

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 10; Vol. 132, pp. 112037. Date of Electronic Publication: 2024 Apr 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.

  • Authors : Zheng R; Department of Medical Immunology, Medical College of Yan'an University, Yanan, Shaanxi, China.; Liu X

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/immunology ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods

  • Source: Frontiers in immunology [Front Immunol] 2024 May 02; Vol. 15, pp. 1383978. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Self-Generating Gold Nanocatalysts in Autologous Tumor Cells for Targeted Catalytic Immunotherapy.

  • Authors : Zeng F; College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing, 210023, China.; Pan Y

Subjects: Gold*/Gold*/Gold*/chemistry ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology

  • Source: Advanced healthcare materials [Adv Healthc Mater] 2024 Jun; Vol. 13 (14), pp. e2303683. Date of Electronic Publication: 2024 Mar 01.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659

Record details

×
Academic Journal

Expanding the Potential of Neoantigen Vaccines: Harnessing Bacille Calmette-Guérin Cell-Wall-Based Nanoscale Adjuvants for Enhanced Cancer Immunotherapy.

  • Authors : Liu K; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Peng J

Subjects: Immunotherapy* ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage

  • Source: ACS nano [ACS Nano] 2024 May 07; Vol. 18 (18), pp. 11910-11920. Date of Electronic Publication: 2024 Apr 29.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

[Therapeutic cancer vaccines: challenges and perspectives].

  • Authors : Colarusso G; Service d'oncologie, Département d'oncologie, Hôpitaux universitaires de Genève, 1211 Genève 14.; Mechahougui H

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/administration & dosage ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/immunology

  • Source: Revue medicale suisse [Rev Med Suisse] 2024 May 15; Vol. 20 (874), pp. 984-989.Publisher: Médecine et Hygiène Country of Publication: Switzerland NLM ID: 101219148 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Advances in traditional herbal formulation based nano-vaccine for cancer immunotherapy: Unraveling the enigma of complex tumor environment and multidrug resistance.

  • Authors : Saeed Y; Guangdong Provincial Key Laboratory of Utilization and Conservation of Food and Medicinal Resources in Northern Region, Shaoguan University, Shaoguan 512005, China. Electronic address: .; Zhong R

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; Neoplasms*/Neoplasms*/Neoplasms*/therapy ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy

  • Source: International immunopharmacology [Int Immunopharmacol] 2024 May 10; Vol. 132, pp. 111948. Date of Electronic Publication: 2024 Mar 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.

  • Authors : Pan Y; The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450014, China.; Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.

Subjects: Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Dendritic Cells*/Dendritic Cells*/Dendritic Cells*/immunology

  • Source: Advanced healthcare materials [Adv Healthc Mater] 2024 May; Vol. 13 (13), pp. e2400068. Date of Electronic Publication: 2024 Feb 15.Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659

Record details

×
Academic Journal

Manganese oxide-constructed multifunctional biomimetic nanovaccine for robust tumor-specific T cell priming and chemodynamic therapy.

  • Authors : Li T; Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510260, China.; Chen G

Subjects: Manganese Compounds*/Manganese Compounds*/Manganese Compounds*/chemistry ; Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/immunology ; Oxides*/Oxides*/Oxides*/chemistry

  • Source: Biomaterials [Biomaterials] 2024 Sep; Vol. 309, pp. 122626. Date of Electronic Publication: 2024 May 20.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8100316 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Periodical

Cancer-vaccine trials give reasons for optimism.

Subjects: Cancer Vaccines*/Cancer Vaccines*/Cancer Vaccines*/therapeutic use ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Immunotherapy*/Immunotherapy*/Immunotherapy*/trends

  • Source: Nature [Nature] 2024 Mar; Vol. 627 (8005), pp. S33.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  23,745 results for ""VACCINES""